Global Zika Virus Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
Table of Contents
1 Market Overview
- 1.1 Zika Virus Introduction
- 1.2 Market Analysis by Type
- 1.2.1 Sexual Transmission
- 1.2.2 Blood Transfusion
- 1.3 Market Analysis by Applications
- 1.3.1 Hospitals
- 1.3.2 Clinics
- 1.3.3 Ambulatory Surgery Centers
- 1.3.4 Others
- 1.4 Market Analysis by Regions
- 1.4.1 North America (United States, Canada and Mexico)
- 1.4.1.1 United States Market States and Outlook (2014-2024)
- 1.4.1.2 Canada Market States and Outlook (2014-2024)
- 1.4.1.3 Mexico Market States and Outlook (2014-2024)
- 1.4.2 Europe (Germany, France, UK, Russia and Italy)
- 1.4.2.1 Germany Market States and Outlook (2014-2024)
- 1.4.2.2 France Market States and Outlook (2014-2024)
- 1.4.2.3 UK Market States and Outlook (2014-2024)
- 1.4.2.4 Russia Market States and Outlook (2014-2024)
- 1.4.2.5 Italy Market States and Outlook (2014-2024)
- 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- 1.4.3.1 China Market States and Outlook (2014-2024)
- 1.4.3.2 Japan Market States and Outlook (2014-2024)
- 1.4.3.3 Korea Market States and Outlook (2014-2024)
- 1.4.3.4 India Market States and Outlook (2014-2024)
- 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
- 1.4.4 South America, Middle East and Africa
- 1.4.4.1 Brazil Market States and Outlook (2014-2024)
- 1.4.4.2 Egypt Market States and Outlook (2014-2024)
- 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
- 1.4.4.4 South Africa Market States and Outlook (2014-2024)
- 1.4.4.5 Turkey Market States and Outlook (2014-2024)
- 1.4.1 North America (United States, Canada and Mexico)
- 1.5 Market Dynamics
- 1.5.1 Market Opportunities
- 1.5.2 Market Risk
- 1.5.3 Market Driving Force
2 Manufacturers Profiles
- 2.1 Bharat Biotech
- 2.1.1 Business Overview
- 2.1.2 Zika Virus Type and Applications
- 2.1.2.1 Product A
- 2.1.2.2 Product B
- 2.1.3 Bharat Biotech Zika Virus Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.2 Inovio Pharmaceuticals and GeneOne Life Sciences
- 2.2.1 Business Overview
- 2.2.2 Zika Virus Type and Applications
- 2.2.2.1 Product A
- 2.2.2.2 Product B
- 2.2.3 Inovio Pharmaceuticals and GeneOne Life Sciences Zika Virus Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.3 Intrexon
- 2.3.1 Business Overview
- 2.3.2 Zika Virus Type and Applications
- 2.3.2.1 Product A
- 2.3.2.2 Product B
- 2.3.3 Intrexon Zika Virus Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.4 Cerus
- 2.4.1 Business Overview
- 2.4.2 Zika Virus Type and Applications
- 2.4.2.1 Product A
- 2.4.2.2 Product B
- 2.4.3 Cerus Zika Virus Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.5 Sanofi
- 2.5.1 Business Overview
- 2.5.2 Zika Virus Type and Applications
- 2.5.2.1 Product A
- 2.5.2.2 Product B
- 2.5.3 Sanofi Zika Virus Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.6 NewLink Genetics
- 2.6.1 Business Overview
- 2.6.2 Zika Virus Type and Applications
- 2.6.2.1 Product A
- 2.6.2.2 Product B
- 2.6.3 NewLink Genetics Zika Virus Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.7 Immunovaccine
- 2.7.1 Business Overview
- 2.7.2 Zika Virus Type and Applications
- 2.7.2.1 Product A
- 2.7.2.2 Product B
- 2.7.3 Immunovaccine Zika Virus Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.8 GlaxoSmithKline
- 2.8.1 Business Overview
- 2.8.2 Zika Virus Type and Applications
- 2.8.2.1 Product A
- 2.8.2.2 Product B
- 2.8.3 GlaxoSmithKline Zika Virus Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Zika Virus Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
- 3.1 Global Zika Virus Sales and Market Share by Manufacturer (2017-2018)
- 3.2 Global Zika Virus Revenue and Market Share by Manufacturer (2017-2018)
- 3.3 Market Concentration Rate
- 3.3.1 Top 3 Zika Virus Manufacturer Market Share in 2018
- 3.3.2 Top 6 Zika Virus Manufacturer Market Share in 2018
- 3.4 Market Competition Trend
4 Global Zika Virus Market Analysis by Regions
- 4.1 Global Zika Virus Sales, Revenue and Market Share by Regions
- 4.1.1 Global Zika Virus Sales and Market Share by Regions (2014-2019)
- 4.1.2 Global Zika Virus Revenue and Market Share by Regions (2014-2019)
- 4.2 North America Zika Virus Sales and Growth Rate (2014-2019)
- 4.3 Europe Zika Virus Sales and Growth Rate (2014-2019)
- 4.4 Asia-Pacific Zika Virus Sales and Growth Rate (2014-2019)
- 4.5 South America Zika Virus Sales and Growth Rate (2014-2019)
- 4.6 Middle East and Africa Zika Virus Sales and Growth Rate (2014-2019)
5 North America Zika Virus by Country
- 5.1 North America Zika Virus Sales, Revenue and Market Share by Country
- 5.1.1 North America Zika Virus Sales and Market Share by Country (2014-2019)
- 5.1.2 North America Zika Virus Revenue and Market Share by Country (2014-2019)
- 5.2 United States Zika Virus Sales and Growth Rate (2014-2019)
- 5.3 Canada Zika Virus Sales and Growth Rate (2014-2019)
- 5.4 Mexico Zika Virus Sales and Growth Rate (2014-2019)
6 Europe Zika Virus by Country
- 6.1 Europe Zika Virus Sales, Revenue and Market Share by Country
- 6.1.1 Europe Zika Virus Sales and Market Share by Country (2014-2019)
- 6.1.2 Europe Zika Virus Revenue and Market Share by Country (2014-2019)
- 6.2 Germany Zika Virus Sales and Growth Rate (2014-2019)
- 6.3 UK Zika Virus Sales and Growth Rate (2014-2019)
- 6.4 France Zika Virus Sales and Growth Rate (2014-2019)
- 6.5 Russia Zika Virus Sales and Growth Rate (2014-2019)
- 6.6 Italy Zika Virus Sales and Growth Rate (2014-2019)
7 Asia-Pacific Zika Virus by Country
- 7.1 Asia-Pacific Zika Virus Sales, Revenue and Market Share by Country
- 7.1.1 Asia-Pacific Zika Virus Sales and Market Share by Country (2014-2019)
- 7.1.2 Asia-Pacific Zika Virus Revenue and Market Share by Country (2014-2019)
- 7.2 China Zika Virus Sales and Growth Rate (2014-2019)
- 7.3 Japan Zika Virus Sales and Growth Rate (2014-2019)
- 7.4 Korea Zika Virus Sales and Growth Rate (2014-2019)
- 7.5 India Zika Virus Sales and Growth Rate (2014-2019)
- 7.6 Southeast Asia Zika Virus Sales and Growth Rate (2014-2019)
8 South America Zika Virus by Country
- 8.1 South America Zika Virus Sales, Revenue and Market Share by Country
- 8.1.1 South America Zika Virus Sales and Market Share by Country (2014-2019)
- 8.1.2 South America Zika Virus Revenue and Market Share by Country (2014-2019)
- 8.2 Brazil Zika Virus Sales and Growth Rate (2014-2019)
- 8.3 Argentina Zika Virus Sales and Growth Rate (2014-2019)
- 8.4 Colombia Zika Virus Sales and Growth Rate (2014-2019)
9 Middle East and Africa Zika Virus by Countries
- 9.1 Middle East and Africa Zika Virus Sales, Revenue and Market Share by Country
- 9.1.1 Middle East and Africa Zika Virus Sales and Market Share by Country (2014-2019)
- 9.1.2 Middle East and Africa Zika Virus Revenue and Market Share by Country (2014-2019)
- 9.2 Saudi Arabia Zika Virus Sales and Growth Rate (2014-2019)
- 9.3 Turkey Zika Virus Sales and Growth Rate (2014-2019)
- 9.4 Egypt Zika Virus Sales and Growth Rate (2014-2019)
- 9.5 Nigeria Zika Virus Sales and Growth Rate (2014-2019)
- 9.6 South Africa Zika Virus Sales and Growth Rate (2014-2019)
10 Global Zika Virus Market Segment by Type
- 10.1 Global Zika Virus Sales, Revenue and Market Share by Type (2014-2019)
- 10.1.1 Global Zika Virus Sales and Market Share by Type (2014-2019)
- 10.1.2 Global Zika Virus Revenue and Market Share by Type (2014-2019)
- 10.2 Sexual Transmission Sales Growth and Price
- 10.2.1 Global Sexual Transmission Sales Growth (2014-2019)
- 10.2.2 Global Sexual Transmission Price (2014-2019)
- 10.3 Blood Transfusion Sales Growth and Price
- 10.3.1 Global Blood Transfusion Sales Growth (2014-2019)
- 10.3.2 Global Blood Transfusion Price (2014-2019)
11 Global Zika Virus Market Segment by Application
- 11.1 Global Zika Virus Sales Market Share by Application (2014-2019)
- 11.2 Hospitals Sales Growth (2014-2019)
- 11.3 Clinics Sales Growth (2014-2019)
- 11.4 Ambulatory Surgery Centers Sales Growth (2014-2019)
- 11.5 Others Sales Growth (2014-2019)
12 Zika Virus Market Forecast (2019-2024)
- 12.1 Global Zika Virus Sales, Revenue and Growth Rate (2019-2024)
- 12.2 Zika Virus Market Forecast by Regions (2019-2024)
- 12.2.1 North America Zika Virus Market Forecast (2019-2024)
- 12.2.2 Europe Zika Virus Market Forecast (2019-2024)
- 12.2.3 Asia-Pacific Zika Virus Market Forecast (2019-2024)
- 12.2.4 South America Zika Virus Market Forecast (2019-2024)
- 12.2.5 Middle East and Africa Zika Virus Market Forecast (2019-2024)
- 12.3 Zika Virus Market Forecast by Type (2019-2024)
- 12.3.1 Global Zika Virus Sales Forecast by Type (2019-2024)
- 12.3.2 Global Zika Virus Market Share Forecast by Type (2019-2024)
- 12.4 Zika Virus Market Forecast by Application (2019-2024)
- 12.4.1 Global Zika Virus Sales Forecast by Application (2019-2024)
- 12.4.2 Global Zika Virus Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
- 13.1 Sales Channel
- 13.1.1 Direct Marketing
- 13.1.2 Indirect Marketing
- 13.1.3 Marketing Channel Future Trend
- 13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
- 15.1 Methodology
Zika virus disease (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika are fever, rash, joint pain, and conjunctivitis. The illness is usually mild with symptoms lasting for several days to a week after being bitten by an infected mosquito. People usually don’t get sick enough to go to the hospital, and they very rarely die of Zika. For this reason, many people might not realize they have been infected. However, Zika virus infection during pregnancy can cause a serious birth defect called microcephaly, as well as other severe fetal brain defects. Once a person has been infected, he or she is likely to be protected from future infections.
Scope of the Report:
Zika virus disease (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika are fever, rash, joint pain, and conjunctivitis. The illness is usually mild with symptoms lasting for several days to a week after being bitten by an infected mosquito. Based on research to date, there is scientific consensus that Zika virus is a cause of microcephaly and GBS.
Zika virus is primarily transmitted to people through the bite of an infected mosquito from the Aedes genus, mainly Aedes aegypti in tropical regions. Sexual transmission of Zika virus is also possible. Other modes of transmission such as blood transfusion are being investigated.
Zika virus is a mosquito-borne flavivirus that was first identified in Uganda in 1947 in monkeys through a network that monitored yellow fever. It was later identified in humans in 1952 in Uganda and the United Republic of Tanzania. Outbreaks of Zika virus disease have been recorded in Africa, the Americas, Asia and the Pacific. From the 1960s to 1980s, human infections were found across Africa and Asia, typically accompanied by mild illness. The first large outbreak of disease caused by Zika infection was reported from the Island of Yap (Federated States of Micronesia) in 2007. In July 2015 Brazil reported an association between Zika virus infection and Guillain-Barré syndrome. In October 2015 Brazil reported an association between Zika virus infection and microcephaly.
The worldwide market for Zika Virus is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Zika Virus in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Bharat Biotech
Inovio Pharmaceuticals and GeneOne Life Sciences
Intrexon
Cerus
Sanofi
NewLink Genetics
Immunovaccine
GlaxoSmithKline
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Sexual Transmission
Blood Transfusion
Market Segment by Applications, can be divided into
Hospitals
Clinics
Ambulatory Surgery Centers
Others
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Zika Virus product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Zika Virus, with price, sales, revenue and global market share of Zika Virus in 2017 and 2018.
Chapter 3, the Zika Virus competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Zika Virus breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Zika Virus market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Zika Virus sales channel, distributors, customers, research findings and conclusion, appendix and data source.